{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:00:33Z","timestamp":1783472433558,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.vaccine.2009.08.024","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T10:13:53Z","timestamp":1251281633000},"page":"6143-6147","source":"Crossref","is-referenced-by-count":12,"title":["Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system"],"prefix":"10.1016","volume":"27","author":[{"given":"Anna P.","family":"Durbin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Setse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Spaeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Lessans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal A.","family":"Halsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.08.024_bib1","series-title":"Fields virology","first-page":"961","article-title":"Flaviviruses","author":"Monath","year":"1996"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.024_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1586\/14760584.7.5.579","article-title":"Yellow fever vaccines and international travelers","volume":"7","author":"Barnett","year":"2008","journal-title":"Expert Rev Vac"},{"key":"10.1016\/j.vaccine.2009.08.024_bib3","series-title":"Yellow fever vaccine","first-page":"959","author":"Monath","year":"2008"},{"issue":"RR-17","key":"10.1016\/j.vaccine.2009.08.024_bib4","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"CDC","year":"2002","journal-title":"MMWR"},{"issue":"9276","key":"10.1016\/j.vaccine.2009.08.024_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.vaccine.2009.08.024_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.vaccine.2009.08.024_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.024_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.trstmh.2007.06.013","article-title":"Acute viscerotropic disease following vaccination against yellow fever","volume":"101","author":"Hayes","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.024_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain","volume":"36","author":"Doblas","year":"2006","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.024_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South Med J"},{"issue":"13","key":"10.1016\/j.vaccine.2009.08.024_bib11","first-page":"936","article-title":"Adverse effects of attenuated yellow fever vaccine with multiple organ injury\u2014a case report","volume":"85","author":"Zhou","year":"2005","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"50","key":"10.1016\/j.vaccine.2009.08.024_bib12","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.024_bib13","unstructured":"PAHO. Final statement by the Pan American Health Organization\/World health Organization (PAHO\/WHO) on investigation of serious adverse events in Peru following receipt of yellow fever vaccine produced by Bio-Manguinhos, Brazil. 2008; 21 March 2008 [cited, 16 June 2008], Available from: http:\/\/www.paho.org\/English\/AD\/FCH\/IM\/PAHO_WHOStatement_YellowFever_17Mar08.pdf."},{"issue":"4932","key":"10.1016\/j.vaccine.2009.08.024_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bmj.2.4932.182","article-title":"Encephalitis in infants following vaccination with 17 D yellow fever virus: report of a further case","volume":"2","author":"Thompson","year":"1955","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.024_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0035-9203(55)90044-4","article-title":"Encephalitis following neurotropic yellow fever vaccine administered by scarification in Nigeria: epidemiological and laboratory studies","volume":"49","author":"Stones","year":"1955","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4892","key":"10.1016\/j.vaccine.2009.08.024_bib16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bmj.2.4892.852","article-title":"Encephalitis in an infant after vaccination with 17 D yellow fever virus","volume":"2","author":"Smith","year":"1954","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.024_bib17","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2009.08.024_bib18","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"issue":"6 (November\u2013December)","key":"10.1016\/j.vaccine.2009.08.024_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.024_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4269\/ajtmh.2006.75.333","article-title":"Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996\u20132004","volume":"75","author":"Vellozzi","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"5 (September\u2013October)","key":"10.1016\/j.vaccine.2009.08.024_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/hv.1.5.2221","article-title":"Yellow fever 17D vaccine safety and immunogenicity in the elderly","volume":"1","author":"Monath","year":"2005","journal-title":"Hum Vac"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.024_bib22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2005.06.044","article-title":"Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits","volume":"151","author":"Spaeder","year":"2006","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.024_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S0034-89102005000300012","article-title":"Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial","volume":"39","author":"Camacho","year":"2005","journal-title":"Rev Saude Publica"},{"issue":"2 (March\u2013April)","key":"10.1016\/j.vaccine.2009.08.024_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4161\/hv.4.2.5216","article-title":"Evaluation of two yellow fever vaccines for routine immunization programs in Argentina","volume":"4","author":"Ripoll","year":"2008","journal-title":"Hum Vac"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.024_bib25","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1245\/s10434-007-9500-y","article-title":"Participation in surgical oncology clinical trials: gender-, race\/ethnicity-, and age-based disparities","volume":"14","author":"Stewart","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.024_bib26","first-page":"218","article-title":"Transient arthritis after rubella vaccination","volume":"118","author":"Cooper","year":"1969","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.024_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.vaccine.2005.07.089","article-title":"Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients","volume":"24","author":"Muralles","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901202X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901202X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T05:21:37Z","timestamp":1558502497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0901202X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":27,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0264410X0901202X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}